Daito Pharmaceutical Co.,Ltd. (TYO:4577)
Japan
· Delayed Price · Currency is JPY 1,260.00
-5.00 (-0.40%)
Apr 28, 2026, 3:30 PM JST
Daito Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2020 - 2016 |
| Market Capitalization | 36,336 | 29,536 | 34,043 | 33,086 | 37,154 | 44,980 | Upgrade
|
| Market Cap Growth | 10.47% | -13.24% | 2.89% | -10.95% | -17.40% | -21.02% | Upgrade
|
| Enterprise Value | 44,689 | 37,736 | 37,799 | 34,956 | 37,065 | 46,116 | Upgrade
|
| Last Close Price | 1260.00 | 969.83 | 1058.51 | 967.02 | 1072.91 | 1314.78 | Upgrade
|
| PE Ratio | 12.67 | 15.48 | 10.33 | 9.19 | 7.96 | 10.59 | Upgrade
|
| Forward PE | 13.97 | 15.15 | 8.98 | 9.39 | 8.00 | 10.05 | Upgrade
|
| PS Ratio | 0.72 | 0.58 | 0.73 | 0.73 | 0.86 | 0.92 | Upgrade
|
| PB Ratio | 0.69 | 0.57 | 0.65 | 0.65 | 0.78 | 1.07 | Upgrade
|
| P/TBV Ratio | 0.71 | 0.57 | 0.66 | 0.66 | 0.79 | 1.09 | Upgrade
|
| P/OCF Ratio | - | 5.01 | 6.57 | 7.96 | 8.50 | 8.68 | Upgrade
|
| EV/Sales Ratio | 0.88 | 0.75 | 0.81 | 0.78 | 0.85 | 0.95 | Upgrade
|
| EV/EBITDA Ratio | - | 5.43 | 5.00 | 3.85 | 3.75 | 5.08 | Upgrade
|
| EV/EBIT Ratio | 12.44 | 14.40 | 9.71 | 6.71 | 5.64 | 7.80 | Upgrade
|
| Debt / Equity Ratio | 0.19 | 0.23 | 0.17 | 0.10 | 0.07 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | - | 1.71 | 1.15 | 0.55 | 0.35 | 0.37 | Upgrade
|
| Net Debt / Equity Ratio | 0.16 | 0.19 | 0.12 | 0.03 | -0.02 | 0 | Upgrade
|
| Net Debt / EBITDA Ratio | - | 1.39 | 0.79 | 0.15 | -0.09 | 0.00 | Upgrade
|
| Net Debt / FCF Ratio | - | -10.85 | -5.77 | -1.00 | 3.63 | -0.02 | Upgrade
|
| Asset Turnover | 0.67 | 0.65 | 0.63 | 0.67 | 0.71 | 0.87 | Upgrade
|
| Inventory Turnover | 2.12 | 2.14 | 1.89 | 1.98 | 1.97 | 2.72 | Upgrade
|
| Quick Ratio | 1.26 | 1.32 | 1.05 | 1.38 | 1.46 | 1.26 | Upgrade
|
| Current Ratio | 2.50 | 2.45 | 2.24 | 2.64 | 2.70 | 2.52 | Upgrade
|
| Return on Equity (ROE) | 5.66% | 3.38% | 6.16% | 7.15% | 10.33% | 10.55% | Upgrade
|
| Return on Assets (ROA) | 2.89% | 2.10% | 3.28% | 4.81% | 6.69% | 6.60% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.45% | 2.61% | 5.31% | 7.31% | 10.20% | 10.62% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.90% | 4.30% | 6.60% | 9.50% | 12.90% | 13.20% | Upgrade
|
| Earnings Yield | 8.14% | 6.46% | 9.68% | 10.88% | 12.56% | 9.44% | Upgrade
|
| FCF Yield | - | -3.02% | -3.05% | -4.08% | -0.69% | -2.53% | Upgrade
|
| Dividend Yield | 3.16% | 3.61% | 2.83% | 2.82% | 2.12% | 1.59% | Upgrade
|
| Payout Ratio | - | 52.31% | 27.53% | 25.86% | 14.14% | 15.50% | Upgrade
|
| Buyback Yield / Dilution | 1.83% | 3.06% | 0.86% | -3.38% | -1.94% | -6.42% | Upgrade
|
| Total Shareholder Return | 4.93% | 6.67% | 3.70% | -0.56% | 0.18% | -4.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.